Publications

Reza G, Jalali, et al. Amplification of the chromosome 3q26 region shows high negative predictive value for nonmalignant transformation of LSIL cytology. Am J Obst Gynecol 2010.

Seppo A, et al. Gain of 3q26: a genetic marker in low-grade squamous intraepithelial lesions (LSIL) of the uterine cervix. Gynecol Oncol 2009; 114:80-3.

Caraway NP, Khanna A, Dawlett M, Guo M, Guo N, Lin E, et al. Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma. Gynecol Oncol 2008;110(1):37-42.

Cao Y, Bryan TM, Reddel RR. Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Sci 2008;99(6):1092-9.

Sokolova I, Algeciras-Schimnich A, Song M, Sitailo S, Policht F, Kipp BR, Voss JS, Halling KC, Ruth A, King W, Underwood D, Brainard J, Morrison L. Chromosomal biomarkers for detection of human papillomavirus associated genomic instability in epithelial cells of cervical cytology specimens. J Mol Diagn 2007;9:604-11.

Wright Jr TC, Massad S, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 2007;197:340-45.

Wright Jr TC. Cervical cancer screening in the 21st century: is it time to retire the PAP smear? Clin Obstet Gynecol 2007;50(2):313-23.

Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J. Chapter 9: clinical applications of HPV testing: a summary of meta-analyses. Vaccine 2006;24(Suppl 3): S3/78-89.

Heselmeyer-Haddad K, Sommerfeld K, White NM, Chaudhri N, Morrison LE, Palanisamy N, et al. Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer. Am J Pathol 2005;166(4):1229-38.

Kilpatrick MW, Tafas T, Evans MI, Jackson LG, Antsaklis A, Brambati B, Tsipouras P. Automated detection of rara fetal cells in maternal blood: eliminating the falsepositive XY signals in XX pregnancies. Am J Obstet Gynecol 2004;190:1571-81.

Munger K, Baldwin A, Edwards KM, et al. Mechanisms of human papilloma virus induced oncogenesis. J Virol 2004;78:11451-60.

ASCUS-LSIL Traige Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188(6):1393-400.

Baldwin P, Laskey R, Coleman N. Translational approaches to improving cervical screening. Nat Rev Cancer 2003;3(3):217-26.

Coste J, Cochand-Priollet B, de Cremoux P, Le Gales C, Cartier I, Molinie V, et al. Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening. BMJ 2003;326(7392):733.

Heselmeyer-Haddad K, Janz V, Castle PE, Chaudhri N, White N, Wilber K, et al. Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. Am J Pathol 2003;163(4):1405-16.

Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al.American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52(6):342-62.

Halling KC, KingW, Sokolova IA, et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 2000;164:1768-75.

Ma Y, Wei S, Lin Y. Pik3ca as an oncogene in cervical cancer. Oncogene 2000;19:2739-44.

Holowaty P, Miller AB, Rohan T, To T. Natural History of Dysplasia of the Uterine Cervix. J Natl Cancer Inst 1999;91:252-58

Iwasaka T, Zheng PS, Yokoyama M, Fukuda K, Nakao Y, Sugimori H. Telomerase activation in cervical neoplasia. Obstet Gynecol 1998;91(2):260-2.

Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998;92(4 Pt 2): 727-35.

Heselmeyer K, Macville M, Schrock E, Blegen H, Hellstrom AC, Shah K, et al. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer 1997;19(4):233-40.

Heselmeyer K, Schrock E, du Manoir S, Blegen H, Shah K, Steinbeck R, et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci U S A 1996;93(1):479-84.

Ostor AG, Mulvany N. The pathology of cervical neoplasia. Curr Opin Obstet Gynecol 1996;8:69-73.

Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266(5193):2011-5.

Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12(2):186-92.

Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986;67:665-9.

Links

American Society for Colposcopy and Cervical Pathology (ASCCP) Practice Recommendations [Updated Nov 13, 2009.]
http://www.asccp.org/edu/practice/cervix/premalignant/epidemiology.shtml

Cervical Cancer Website of the National Cancer Institute
http://www.cancer.gov/cancertopics/types/cervical

Cervical Cancer Reference Information. American Cancer Society
http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_is_cervical_cancer_8.asp

Cervical Cancer. U.S. Department of Health & Human Services
http://womenshealth.gov/faq/ccervix.htm

Cervical Cancer. MedlinePlus. U.S. National Library of Medicine and the National Institutes of Health
http://www.nlm.nih.gov/medlineplus/cervicalcancer.html

National Cervical Cancer Coalition (NCCC)
http://www.nccc-online.org/